Grifols · 8 hours ago
Intern - Process Development
Grifols is a global healthcare company that has been working to improve the health and well-being of people around the world since 1909. They are seeking a summer intern to aid in the formulation development of protein products, where the intern will be trained in formulating proteins and executing experiments to evaluate their stability.
BiotechnologyHealth CareManufacturing
Responsibilities
Aid in the formulation development of Grifols’s protein products
Train in formulating proteins in multiple buffers
Execute experiments to characterize and evaluate stability using viscosity, high-performance liquid chromatography (HPLC), and dynamic light scattering (DLS) measurements
Learn how to interpret complex data and generate presentations in preparation for a presentation to management that summarizes the work at the conclusion of their internship
Qualification
Required
Candidate must be currently enrolled in a 4-year degree program pursuing a bachelor's degree in chemistry, Biochemistry, Engineering or related fields as a rising junior or senior; can also be a current Master's or PhD student
Candidate must currently have a GPA of 3.0 or higher
Proficiency in Microsoft Office software (Word, Excel, PowerPoint)
Ability to perform literature searches, read laboratory procedures, and document work in a laboratory notebook
Proficiency in laboratory skills, including pipetting, use of balance, volumetric glassware, making solutions, and laboratory safety awareness
Company
Grifols
Grifols is a global healthcare company.
H1B Sponsorship
Grifols has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2023 (2)
2022 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.51BKey Investors
Michael J. Fox Foundation
2025-01-14Grant· $21M
2024-06-04Post Ipo Debt· $1.41B
2024-04-23Post Ipo Debt· $1.07B
Leadership Team
Recent News
2025-12-24
Pharma Letter
2025-11-28
Company data provided by crunchbase